Literature DB >> 9541586

Calnexin expression does not enhance the generation of MHC class I-peptide complexes.

S A Prasad1, J W Yewdell, A Porgador, B Sadasivan, P Cresswell, J R Bennink.   

Abstract

We investigated the requirement for calnexin in the biogenesis of MHC class I molecules. Mutant human cells lacking calnexin were infected with recombinant vaccinia viruses encoding mouse MHC class I molecules, Kd, Kb, Kk, Dd, Db, and Ld. Flow cytometry indicated that each of the six MHC class I allomorphs was transported to the cell surface at similar rates in calnexin-deficient cells and transfectants expressing calnexin. For Kb and Kd, the calnexin-independent biogenesis occurred regardless of whether the MHC class I molecules contained human or mouse beta 2-microglobulin. Also addressed was the effect of calnexin on the surface expression of Kb molecules bearing the immunodominant peptide from ovalbumin (OVA257-264). This was detected with a recently described monoclonal antibody specific for the Kb/peptide complex. Calnexin expression had no significant effect on the formation of Kb/peptide complexes generated from full-length OVA, cytosolic OVA257-264, or endoplasmic reticulum-targeted OVA257-264, which was expressed in the presence of the herpes simplex virus ICP47 protein to ensure detection of TAP-independent peptide-MHC class I complexes. Complementary results were obtained with TAP-independent formation of Kd/ peptide complexes. These findings indicate that calnexin is not required for the efficient assembly of MHC class I molecules with TAP-dependent or independent peptides.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9541586     DOI: 10.1002/(SICI)1521-4141(199803)28:03<907::AID-IMMU907>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

Review 1.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression.

Authors:  Angela Denzel; Maurizio Molinari; Cesar Trigueros; Joanne E Martin; Shanti Velmurgan; Sue Brown; Gordon Stamp; Michael J Owen
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

3.  Calnexin improves the folding efficiency of mutant rhodopsin in the presence of pharmacological chaperone 11-cis-retinal.

Authors:  Syed M Noorwez; Reddy Ranjith K Sama; Shalesh Kaushal
Journal:  J Biol Chem       Date:  2009-10-02       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.